WOLVERINE ASSET MANAGEMENT LLC - NEVRO CORP ownership

NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 19 filers reported holding NEVRO CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of NEVRO CORP
ValueSharesWeighting
Q4 2022$32,902,720
-27.0%
35,866,000
-25.1%
0.34%
-29.8%
Q3 2022$45,100,000
-5.2%
47,866,000
-5.0%
0.49%
+2.1%
Q2 2022$47,555,000
-11.7%
50,366,0000.0%0.48%
-9.5%
Q1 2022$53,863,000
+3291.9%
50,366,000
+3469.5%
0.53%
+3406.7%
Q4 2021$1,588,000
-97.9%
1,411,000
-96.8%
0.02%
-97.5%
Q2 2021$77,351,000
+11.2%
44,563,000
+0.1%
0.59%
+0.2%
Q1 2021$69,564,000
+138.0%
44,534,000
+178.3%
0.59%
+173.5%
Q4 2020$29,227,000
+17.2%
16,000,0000.0%0.22%
-3.2%
Q3 2020$24,947,000
+13.7%
16,000,0000.0%0.22%
+0.9%
Q2 2020$21,942,00016,000,0000.22%
Other shareholders
NEVRO CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Perceptive Advisors 9,000,000$135,324,0001.71%
DeepCurrents Investment Group LLC 21,930,000$33,750,0001.16%
WOLVERINE ASSET MANAGEMENT LLC 44,534,000$69,564,0000.59%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 12,000,000$18,208,0000.38%
Context Capital Management, LLC 2,000$3,084,0000.30%
ZAZOVE ASSOCIATES LLC 1,500,000$2,276,0000.27%
Polar Asset Management Partners Inc. 17,500,000$26,683,0000.26%
CSS LLC/IL 2,500,000$3,780,0000.16%
Verition Fund Management LLC 7,486,000$11,543,0000.13%
PFM Health Sciences, LP 2,000,000$3,032,0000.09%
View complete list of NEVRO CORP shareholders